Formulación en aerosol para inhalación de beta-agonistas
摘要
The invention relates to a propellant-free aerosol formulation for inhalation, which comprises one or more compounds of general formula (1), wherein the groups R<1>, R<2>, R<3> and X<-> are defined as in the claims and in the description.